FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mohamad Mohty

Research Profile

Procedures

Disorders

Concepts & Ideas

Anatomy

Dendritic Cells

Living Beings

Phenomena

Recurrence

Chemicals & Drugs

Antilymphocyte Serum

Co-author Network

Publications

TOP 3
Sophie Park; Marie Robin; Gérard Socié; Reza Tabrizi; Norbert Vey; Ibrahim Yakoub-Agha; Yves Beguin; Marc Bernard; Jean-Henri Bourhis; Thierry de Revel; Eric DECONINCK; Jacques Delaunay; Nathalie Dhedin; François Dreyfus; Pierre Fenaux; Anne Huynh; Myriam Labopin; Simona Lapusan; Bruno Lioure; Mauricette Michallet; Mohamad Mohty
Allogeneic stem cell transplantation for chronic myelomonocytic leukemia: a report from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire.
S P Chantepie; Nathalie Contentin; Eric DECONINCK; Véronique Lhéritier; Mohamad Mohty; N Raus; M Robin; Reza Tabrizi; Agnès Buzyn; Oumedaly Reman
Treatment of adult ALL with central nervous system involvement at diagnosis using autologous and allogeneic transplantation: a study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
Tereza Coman; Sylvie François; Olivier Hermine; Anne Huynh; Simona Lapusan; Bruno Lioure; Sébastien Maury; Mauricette Michallet; Noël Milpied; Mohamad Mohty; Gérard Socié; Madalina Uzunov; Stéphane Vigouroux; Ibrahim Yakoub-Agha; Emmanuel Bachy; Jean-Henri Bourhis; Alain Brebion; Marie Thérèse Rubio
Lenalidomide as salvage treatment for multiple myeloma relapsing after allogeneic hematopoietic stem cell transplantation: a report from the French Society of Bone Marrow and Cellular Therapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mohamad Mohty (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sophie Park; Marie Robin; Gérard Socié; Reza Tabrizi; Norbert Vey; Ibrahim Yakoub-Agha; Yves Beguin; Marc Bernard; Jean-Henri Bourhis; Thierry de Revel; Eric DECONINCK; Jacques Delaunay; Nathalie Dhedin; François Dreyfus; Pierre Fenaux; Anne Huynh; Myriam Labopin; Simona Lapusan; Bruno Lioure; Mauricette Michallet; Mohamad Mohty
Allogeneic stem cell transplantation for chronic myelomonocytic leukemia: a report from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire.
European journal of haematology 2013;90(5):355-64.
2013: S P Chantepie; Nathalie Contentin; Eric DECONINCK; Véronique Lhéritier; Mohamad Mohty; N Raus; M Robin; Reza Tabrizi; Agnès Buzyn; Oumedaly Reman
Treatment of adult ALL with central nervous system involvement at diagnosis using autologous and allogeneic transplantation: a study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
Bone marrow transplantation 2013;48(5):684-90.
2013: Tereza Coman; Sylvie François; Olivier Hermine; Anne Huynh; Simona Lapusan; Bruno Lioure; Sébastien Maury; Mauricette Michallet; Noël Milpied; Mohamad Mohty; Gérard Socié; Madalina Uzunov; Stéphane Vigouroux; Ibrahim Yakoub-Agha; Emmanuel Bachy; Jean-Henri Bourhis; Alain Brebion; Marie Thérèse Rubio
Lenalidomide as salvage treatment for multiple myeloma relapsing after allogeneic hematopoietic stem cell transplantation: a report from the French Society of Bone Marrow and Cellular Therapy.
Haematologica 2013;98(5):776-83.
2013: A Clavert; J Delaunay; V Dubruille; Thomas Gastinne; T Guillaume; Steven Le Gouill; Béatrice Mahe; N Blin; Patrice Chevallier; Philippe Moreau; Mohamad Mohty
Safety and efficacy of rituximab in steroid-refractory chronic GVHD.
Bone marrow transplantation 2013;48(5):734-6.
2013: Patrice Chevallier; Sophie Derenne; Julie Esbelin; Thierry Guillaume; Marina Illiaquer; Mohamad Mohty; Lucie Planche; Nelly Robillard; Veronique Stocco; Fabienne Auffray; Marie-Christine Bene; Celine Bodin-Bressollette; Berthe-Marie Imbert-Marcille
HHV-6 cell receptor CD46 expression on various cell subsets of six blood and graft sources: a prospective series.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2013;56(4):331-5.
2013: Amandine Le Bourgeois; Steven Le Gouill; Elsa Lestang; Béatrice Mahe; Mohamad Mohty; Philippe Moreau; Lucie Planche; Virginie Roland; Benoit Tessoulin; Aline Clavert; Jacques Delaunay; Viviane Dubruille; Thomas Gastinne; Thierry Guillaume; Sameh Ayari; Nicolas Blin; Patrice Chevallier
Prognostic impact of immune status and hematopoietic recovery before and after fludarabine, IV busulfan, and antithymocyte globulins (FB2 regimen) reduced-intensity conditioning regimen (RIC) allogeneic stem cell transplantation (allo-SCT).
European journal of haematology 2013;90(3):177-86.
2013: Nicolaus Kröger; V Leblond; N Milpied; Mohamad Mohty; M Robin; N Schaap; Anja van Biezen; L Volin; Tatjana Zabelina; H Alchalby; J Berger; D Blaise; Theo de Witte; L de Wreede; J Finke
Allogeneic stem cell transplantation for older advanced MDS patients: improved survival with young unrelated donor in comparison with HLA-identical siblings.
Leukemia 2013;27(3):604-9.
2013: Mauricette Michallet; Noel Milpied; Mohamad Mohty; Stéphane Morisset; Mohamad Sobh; Gerard Socie; Reza Tabrizi; Jacques-O Bay; Pierre Bordigoni; Jean El-Cheikh; Hélène Labussière-Wallet; Didier Blaise
Rituximab, fludarabine, and total body irradiation as conditioning regimen before allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukemia: long-term prospective multicenter study.
Experimental hematology 2013;41(2):127-33.
2013: Nigel Russell; Daniel Shaheen; Nicky Whitaker; Arnold Willemsen; Kenny Douglas; Anthony D Ho; Giuseppe Milone; Mohamad Mohty; G J Ossenkoppele; Macarena Ortiz Pareja; Kristina Carlson; Christian Chabannon
Plerixafor and granulocyte colony-stimulating factor for first-line steady-state autologous peripheral blood stem cell mobilization in lymphoma and multiple myeloma: results of the prospective PREDICT trial.
Haematologica 2013;98(2):172-8.
2013: Didier Blaise; Jean-Marie Boher; Jean-Michel Boiron; Agnes Boyer-Chammard; Luca Castagna; Christian Chabannon; Catherine Faucher; Nathalie Fegueux; Sabine Fürst; Hélène Labussière-Wallet; Anne-Gaëlle Le Corroller-Soriano; Valerie-Jeanne Bardou; Jacques-Olivier Bay; Noël Milpied; Mohamad Mohty; Reza Tabrizi; Mauricette Michallet
Randomized study of 2 reduced-intensity conditioning strategies for human leukocyte antigen-matched, related allogeneic peripheral blood stem cell transplantation: prospective clinical and socioeconomic evaluation.
Cancer 2013;119(3):602-11.
2013: Damien Roos-Weil; Giuseppe Rossi; Anna Sureda; William Arcese; Dietrich W Beelen; Ariane Boumendil; Dominique Bron; Enric Carreras; Jan J Cornelissen; Sascha Dietrich; Peter Dreger; Arturo Iriondo Atienza; Fabrice Jardin; Nicolaus Kröger; Giuseppe Milone; Mohamad Mohty; Christina Peters; Emmanuelle Polge; Vanderson Rocha
Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation.
Blood 2013;121(3):440-6.
2012: Gandhi Damaj; Charles Dauriac; Eric DECONINCK; Alain Duhamel; Jean El-Cheikh; Nathalie Fegueux; Ierre Fenaux; Alice Garnier; Federico Garnier; Gaelle Guillerm; Anne Huynh; Faeyzeh Legrand; Natacha Maillard; Zora Marjanovic; Jean-Pierre Marolleau; Mauricette Michallet; Mohamad Mohty; Sophie Park; Marie Robin; Marie-Thérèse Rubio; Aline Schmidt-Tanguy; Stephane Vigouroux; Lionel Ades; Jacques-Olivier Bay; Yves Beguin; Pierre Bories; Claude-Eric Bulabois; Laurence Clement; Jérôme Cornillon; Ibrahim Yakoub-Agha
Impact of azacitidine before allogeneic stem-cell transplantation for myelodysplastic syndromes: a study by the Société Française de Greffe de Moelle et de Thérapie-Cellulaire and the Groupe-Francophone des Myélodysplasies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(36):4533-40.
2012: Régis Peffault de Latour; Hubert Schrezenmeier; Andrea Bacigalupo; Didier Blaise; SOPHIE DE GUIBERT; Carmino A de Souza; Judith C Marsh; Mohamad Mohty; Jakob Passweg; Louis Terriou; Andre Tichelli; Stephane Vigouroux; Roelf Willemze; Jean Yves Mary; Gerard Socie
Allogeneic stem cell transplantation in paroxysmal nocturnal hemoglobinuria.
Haematologica 2012;97(11):1666-73.
2012: O Ringdén; V Rocha; L Volin; R Arnold; D W Beelen; L Brinch; D Bunjes; G Ehninger; J Finke; H T Greinix; Slawomira Kyrcz-Krzemien; Myriam Labopin; Mohamad Mohty; D Niederwieser
Bone marrow or peripheral blood stem cell transplantation from unrelated donors in adult patients with acute myeloid leukaemia, an Acute Leukaemia Working Party analysis in 2262 patients.
Journal of internal medicine 2012;272(5):472-83.
2012: Nina Worel; Dominik Selleslag; Jane F Apperley; Grzegorz W Basak; Kenneth W Douglas; Rafael F Duarte; Ian H Gabriel; Catarina Geraldes; Kai Hübel; Ozren Jaksic; Zdenek Koristek; Francesco Lanza; Roberto Lemoli; Gabor Mikala; Mohamad Mohty
European data on stem cell mobilization with plerixafor in patients with nonhematologic diseases: an analysis of the European consortium of stem cell mobilization.
Transfusion 2012;52(11):2395-400.
2012: Jan J Cornelissen; Alois Gratwohl; Gunnar Juliusson; Bob Löwenberg; Mohamad Mohty; Dietger Niederwieser; Zdenek Råcil; Jacob M Rowe; Nigel Russell; Richard F Schlenk; Jorge Sierra; Gerard Socie; Martin Bornhäuser; Gert J Ossenkoppele
The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach.
Nature reviews. Clinical oncology 2012;9(10):579-90.
2012: Jihane Frikeche; Béatrice Gaugler; Marc Grégoire; Eolia Brissot; Zinaida Peric; Mohamad Mohty
Impact of HDAC inhibitors on dendritic cell functions.
Experimental hematology 2012;40(10):783-91.
2012: Steven Le Gouill; C Leux; Noël Milpied; U Bacher; K Bouabdallah; Claude-Eric Bulabois; Agnès Buzyn; Nathalie Dhedin; Jean-Luc Harousseau; T Kanouni; N Kröger; M P Moles; Philippe Moreau; Arnon Nagler; S Ocheni; Bernard Rio; A Shimoni; Olivier Tournilhac; Ibrahim Yakoub-Agha; Mohamad Mohty
Reduced-intensity conditioning allogeneic stem cell transplantation for relapsed/refractory mantle cell lymphoma: a multicenter experience.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(10):2695-703.
2012: Patrice Chevallier; Fabio Ciceri; Chistoph Faul; Juergen Finke; Arnold Ganser; Gaelle Guillerm; Anne Huynh; Hans-Jochem Kolb; Myriam Labopin; Bruno Lioure; Arnon Nagler; Emmanuelle Polge; Joerg Schubert; Stefanie Buchholz; Mohamad Mohty
Clofarabine-containing conditioning regimen for allo-SCT in AML/ALL patients: a survey from the Acute Leukemia Working Party of EBMT.
European journal of haematology 2012;89(3):214-9.
2012: Arnon Nagler; Dietger Niederwieser; Eefke Petersen; Vanderson Rocha; Avichai Shimoni; Gerard J Socié; Lars Vindelov; Renate Arnold; Andrea Bacigalupo; Didier Blaise; Paul Brown; Jan J Cornelissen; Hakan Goker; John Gribben; Jeroen J W M Janssen; Myriam Labopin; Claes Malm; Noel Milpied; Mohamad Mohty; Ghulam J Mufti
Mobilized peripheral blood stem cells compared with bone marrow from HLA-identical siblings for reduced-intensity conditioning transplantation in acute myeloid leukemia in complete remission: a retrospective analysis from the Acute Leukemia Working Party of EBMT.
European journal of haematology 2012;89(3):206-13.
2012: Arnon Nagler; Dietger Niederwieser; Vanderson Rocha; Nigel H Russell; Avichai Shimoni; Axel R Zander; Ghulam J Mufti; Renate Arnold; Donald W Bunjes; Jan J Cornelissen; Charles Craddock; Arnold Ganser; Hildegard Greinix; Graham H Jackson; Slawomira Kyrcz-Krzemien; Myriam Labopin; Mohamad Mohty
Mobilized peripheral blood stem cells compared with bone marrow as the stem cell source for unrelated donor allogeneic transplantation with reduced-intensity conditioning in patients with acute myeloid leukemia in complete remission: an analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(9):1422-9.
2012: Pierre Peterlin; Virginie Roland; Soraya Wuilleme; Christophe Leux; Béatrice Mahé; Noel Milpied; Mohamad Mohty; Anne Moreau; Philippe Moreau; Sameh Ayari; Nicolas Blin; Patrice Chevallier; Aline Clavert; Jacques Delaunay; Christelle Dousset; Viviane Dubruille; Thomas Gastinne; Thierry Guillaume; Jean-Luc Harousseau; Steven Le Gouill
Is ASCT with TBI superior to ASCT without TBI in mantle cell lymphoma patients?
Transplantation 2012;94(3):295-301.
2012: Mauricette Michallet; Noel Milpied; Mohamad Mohty; Stéphane Morisset; Franck E Nicolini; Mohamad Sobh; Reza Tabrizi; Nathalie Tedone; Stéphane Vigouroux; Joachim Baumgart; Jacques-Olivier Bay; Sabine Fürst; Jean-Luc Harousseau; Hélène Labussière; Didier Blaise
Phase II prospective study of treosulfan-based reduced-intensity conditioning in allogeneic HSCT for hematological malignancies from 10/10 HLA-identical unrelated donor.
Annals of hematology 2012;91(8):1289-97.
2012: Jean El-Cheikh; Catherine Faucher; Sabine Fürst; Angela Granata; Mohamad Mohty; Claire Oudin; Anne-Marie Stoppa; Jean-Marie Boher; Reda Bouabdallah; Luca Castagna; Diane Coso; Roberto Crocchiolo; Jean-Marc Schiano de Colella; Didier Blaise
Allogeneic transplant for myeloma in the era of new drugs: have the outcomes improved?
Leukemia & lymphoma 2012;53(8):1630-2.
2012: T Guillaume; Steven Le Gouill; Béatrice Mahé; P Moreau; F Rialland; S Ayari; N Blin; P Chevallier; A Clavert; J Delaunay; V Dubruille; Thomas Gastinne; B Gaugler; Mohamad Mohty
Escalated lymphodepletion followed by donor lymphocyte infusion can induce a graft-versus-host response without overwhelming toxicity.
Bone marrow transplantation 2012;47(8):1112-7.
2012: Laurent Garderet; Norbert-Claude Gorin; Alois Gratwohl; Roman Hajek; Jean-Luc Harousseau; Bernd Hertenstein; Simona Iacobelli; Nicolas Ketterer; Christian Koenecke; Brigitte Kolb; Ingrid Lafon; Heinz Ludwig; Tamas Masszi; Mauricette Michallet; Giuseppe Milone; Mohamad Mohty; Philippe Moreau; Curly Morris; Dietger Niederwieser; Francesco Onida; Brigitte Pegourie; Marleen van Os; Andrew Cakana; Philippe Casassus; Carine Chaleteix; Theo de Witte; Michel DIB; Chantal Doyen; Jean Fontan; Gösta Gahrton
Superiority of the triple combination of bortezomib-thalidomide-dexamethasone over the dual combination of thalidomide-dexamethasone in patients with multiple myeloma progressing or relapsing after autologous transplantation: the MMVAR/IFM 2005-04 Randomized Phase III Trial from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(20):2475-82.
2012: Cyrille Touzeau; Patrice Chevallier; Anne Devys; Gilles Folléa; Katia Gagne; Patricia Herry; Mohamad Mohty; Philippe Moreau; Véronique Sébille; Anne Cesbron Gautier
Investigation of the impact of HLA-DPB1 matching status in 10/10 HLA matched unrelated hematopoietic stem cell transplantation: results of a French single center study.
Human immunology 2012;73(7):711-4.
2012: Céline Bossard; Patrice Chevallier; J Delaunay; T Guillaume; F Malard; Mohamad Mohty; Jean-François Mosnier; P Saas; P Tiberghien; J Arbez; B Gaugler
Plasmacytoid dendritic cells and Th17 immune response contribution in gastrointestinal acute graft-versus-host disease.
Leukemia 2012;26(7):1471-4.
2012: Cyrille Touzeau; Steven Le Gouill; Martine Pennetier; Pierre Peterlin; Lucie Planche; Virginie Roland; Benoit Tessoulin; Nicolas Blin; Aline Clavert; Viviane Dubruille; Marion Loirat; Beatrice Mahe; Florent Malard; Mohamad Mohty; Philippe Moreau
Efficacy of lenalidomide plus dexamethasone in patients older than 75 years with relapsed multiple myeloma.
Leukemia & lymphoma 2012;53(7):1318-20.
2012: Jihane Frikeche; Béatrice Gaugler; Marc Grégoire; Eolia Brissot; Thomas Simon; Mohamad Mohty
Impact of valproic acid on dendritic cells function.
Immunobiology 2012;217(7):704-10.
2012: Kate Cwynarski; Theo de Witte; Liesbeth de Wreede; Donald Bunjes; Vladimir Koza; Bernd Metzner; Mohamad Mohty; Arnon Nagler; Kari Remes; Nigel Russell; Marijke Scholten; Stephan Stilgenbauer; Anna Sureda; Anja van Biezen; Peter Dreger
Autologous and allogeneic stem-cell transplantation for transformed chronic lymphocytic leukemia (Richter's syndrome): A retrospective analysis from the chronic lymphocytic leukemia subcommittee of the chronic leukemia working party and lymphoma working party of the European Group for Blood and Marrow Transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(18):2211-7.
2012: Marion Strullu; Caroline Thomas; Fanny Rialland; Xavier Rialland; Nicolas Blin; Eolia Brissot; Xavier Cahu; Nadege Corradini; Françoise Méchinaud; Mohamad Mohty
Allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning regimen in children: a single-center experience.
European journal of haematology 2012;88(6):504-9.
2012: Mohamad Mohty; Patrice Chevallier
Azacitidine after allo-SCT: the good without the bad?
Blood 2012;119(14):3199-200.
2012: Olle Ringdén; Gerard Socie; Giovanni F Torelli; Liisa Volin; Arturo I Atienza; Michel Attal; Catherine Cordonnier; Norbert-Claude Gorin; Olivier Hermine; Jean P Jouet; Myriam Labopin; Mauricette Michallet; Noel Milpied; Mohamad Mohty
Growth factor-associated graft-versus-host disease and mortality 10 years after allogeneic bone marrow transplantation.
British journal of haematology 2012;157(2):220-9.
2012: Mona Benrashid; Mohamad Mohty; Kim Moyers; Bipin N Savani
Vitamin D deficiency, autoimmunity, and graft-versus-host-disease risk: Implication for preventive therapy.
Experimental hematology 2012;40(4):263-7.
2012: Claire Fabre; Nathalie Fegueux; Sylvie François; Frédéric Garban; serge koscielny; Simona Lapusan; Natacha Maillard; Mauricette Michallet; Mohamad Mohty; Gérard Socié; Reza Tabrizi; Madalina Uzunov; Ibrahim Yakoub-Agha; Didier Blaise; Nathalie Contentin; Jean-Henri Bourhis
Younger donor's age and upfront tandem are two independent prognostic factors for survival in multiple myeloma patients treated by tandem autologous-allogeneic stem cell transplantation: a retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
Haematologica 2012;97(4):482-90.
2012: Catherine Faucher; Dominique Genre; A G Le Corroller Soriano; D Maraninchi; M Michallet; J P Moatti; Mohamad Mohty; Anne-Marie Stoppa; Norbert Vey; P Viens; J O Bay; C Chabannon; Benjamin Esterni; Didier Blaise
Randomized study of early hospital discharge following autologous blood SCT: medical outcomes and hospital costs.
Bone marrow transplantation 2012;47(4):549-55.
2012: Patrice Chevallier; Jacques Delaunay; Marie-Christine Bene; Marc Bernard; Jean-Sebastien Blade; Sylvain Carras; Cecile Chabrot; Aude Charbonnier; Anne Etienne; Cecile Fohrer; Thierry Guillaume; Norbert Ifrah; Sebastien Maury; Mohamad Mohty; Emmanuel Raffoux; Nelly Robillard; Pascaline Talmant; Herve Dombret
Trastuzumab for treatment of refractory/relapsed HER2-positive adult B-ALL: results of a phase 2 GRAALL study.
Blood 2012;119(11):2474-7.
2012: Salut Brunet; Jan Cornelissen; Jordi Esteve; Alois Gratwohl; Anna P Iori; Myriam Labopin; Mohamad Mohty; Jorge Sierra; Gerard Socié; Leo F Verdonck; Liisa Volin; Vanderson Rocha
Impact of FLT3 internal tandem duplication on the outcome of related and unrelated hematopoietic transplantation for adult acute myeloid leukemia in first remission: a retrospective analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(7):735-41.
2012: Patrice Chevallier; Jacques Delaunay; Pierre-Yves Dumas; Marion Eveillard; Thierry Guillaume; Eric Lippert; Mohamad Mohty; Arnaud Pigneux; Nelly Robillard; Sameh Ayari; Thibaut Leguay
Rituximab for the treatment of adult relapsed/refractory CD20 positive B-ALL patients: a pilot series.
Leukemia research 2012;36(3):311-5.
2012: Ibrahim Yakoub-Agha; Robert Zerbib; Lotfi Benboubker; Christian Berthou; Philippe Casassus; Ghandi Damaj; Mamoun Dib; Chantal Doyen; Thierry Facon; Jean-Luc Harousseau; Cyrille Hulin; Frédéric Maloisel; Gérald Marit; Jean-Yves Mary; Mohamad Mohty; Philippe Moreau; Brigitte Pegourie; Philippe Rodon; Borhane Slama; Anne-Marie Stoppa; Laurent Voillat
Low-dose vs. high-dose thalidomide for advanced multiple myeloma: a prospective trial from the Intergroupe Francophone du Myélome.
European journal of haematology 2012;88(3):249-59.
2012: Christoph Schmid; Gerard Socie; Michael Stadler; Reza Tabrizi; Lars Vindeløv; Jiri Vorlicek; Luca Castagna; Jan Cornelissen; Michele Falda; Graham Jackson; Nicolaus Kröger; Jürgen Kuball; Myriam Labopin; Per Ljungman; Mohamad Mohty; Arnon Nagler; Dietger Niederwieser; Emmanuelle Polge; Andreas Rank; Vanderson Rocha
Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation.
Blood 2012;119(6):1599-606.
2012: Z Peric; B Saulquin; Philippe Moreau; S Ayari; N Blin; E Brissot; X Cahu; Patrice Chevallier; Marianne Coste-Burel; J Delaunay; V Dubruille; Thomas Gastinne; T Guillaume; Jean-Luc Harousseau; Berthe-Marie Imbert-Marcille; Steven Le Gouill; Béatrice Mahé; F Malard; Mohamad Mohty
Features of EBV reactivation after reduced intensity conditioning unrelated umbilical cord blood transplantation.
Bone marrow transplantation 2012;47(2):251-7.
2012: Nicolaus Kröger; Mohamad Mohty; Arnon Nagler; Qing Yi
Immunotherapy for multiple myeloma.
Clinical & developmental immunology 2012;2012():797165.
2011: Jihane Frikeche; Béatrice Gaugler; Marc Grégoire; Eolia Brissot; Aline Clavert; Jacques Delaunay; Mohamad Mohty
Impact of the hypomethylating agent 5-azacytidine on dendritic cells function.
Experimental hematology 2011;39(11):1056-63.
2011: Florent Malard; Noel Miplied; Philippe Moreau; Sameh Ayari; Nicolas Blin; Eolia Brissot; Xavier Cahu; Patrice Chevallier; Aline Clavert; Jacques Delaunay; Viviane Dubruille; Thomas Gastinne; Thierry Guillaume; Jean-Luc Harousseau; Steven Le Gouill; Béatrice Mahe; Mohamad Mohty
Fludarabine, antithymocyte globulin, and very low-dose busulfan for reduced-intensity conditioning before allogeneic stem cell transplantation in patients with lymphoid malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(11):1698-703.
2011: Mehdi Hamadani; Mohamad Mohty; Mohamed A Kharfan-Dabaja
Reduced-intensity conditioning allogeneic hematopoietic cell transplantation in adults with acute myeloid leukemia.
Cancer control : journal of the Moffitt Cancer Center 2011;18(4):237-45.
2011: Patrice Chevallier; Jan Cornelissen; Myriam Labopin; Mohamad Mohty; Vanderson Rocha; Gérard Socié
Allogeneic hematopoietic stem cell transplantation for isolated and leukemic myeloid sarcoma in adults: a report from the Acute Leukemia Working Party of the European group for Blood and Marrow Transplantation.
Haematologica 2011;96(9):1391-4.
2011: Christian Chabannon; Sarah Habibi; Boris Calmels; Mohamad Mohty; Anne-Marie Imbert
[New molecular targets and new clinical practices for hematopoietic stem cell mobilization].
Bulletin du cancer 2011;98(8):951-61.
2011: Steven Le Gouill; Mohamad Mohty; Thomas Gastinne; Thierry Guillaume; Philippe Moreau
Allogeneic stem cell transplantation in mantle cell lymphoma: where are we now and which way should we go?
Seminars in hematology 2011;48(3):227-39.
2011: Mohamad Mohty; Anthony D Ho
In and out of the niche: perspectives in mobilization of hematopoietic stem cells.
Experimental hematology 2011;39(7):723-9.
2011: L Castagna; Jean El-Cheikh; Benjamin Esterni; Catherine Faucher; Sabine Fürst; N Marchetti; Mohamad Mohty; Anne-Marie Stoppa; Norbert Vey; Reda Bouabdallah; Didier Blaise
Retrospective analysis of common scoring systems and outcome in patients older than 60 years treated with reduced-intensity conditioning regimen and alloSCT.
Bone marrow transplantation 2011;46(7):1000-5.
2011: Z Peric; B Saulquin; Philippe Moreau; S Ayari; N Blin; E Brissot; X Cahu; Patrice Chevallier; Marianne Coste-Burel; J Delaunay; V Dubruille; Thomas Gastinne; T Guillaume; Jean-Luc Harousseau; Berthe-Marie Imbert-Marcille; Steven Le Gouill; Béatrice Mahe; F Malard; Noël Milpied; Mohamad Mohty
Features of Epstein-Barr Virus (EBV) reactivation after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation.
Leukemia 2011;25(6):932-8.
2011: Patrice Chevallier; P Cornillet-Lefebvre; M-C Bene; O Blanchet; K Filanovsky; N Gachard; Jean-Luc Harousseau; M Hunault; N Ifrah; Myriam Labopin; L Lode; I Luquet; Noël Milpied; Mohamad Mohty; A Pigneux; T Prebet; S Richebourg; P Turlure; N Vey; J Delaunay
A new Leukemia Prognostic Scoring System for refractory/relapsed adult acute myelogeneous leukaemia patients: a GOELAMS study.
Leukemia 2011;25(6):939-44.
2011: V Roland; Caroline Bodet-Milin; Anne Moreau; Thomas Gastinne; Béatrice Mahé; V Dubruille; Hervé Maisonneuve; Nadine Juge-Morineau; Philippe Moreau; Henri Jardel; L Planche; Mohamad Mohty; P Moreau; Jean-Luc Harousseau; Françoise Kraeber-Bodéré; Steven Le Gouill
Impact of high-dose chemotherapy followed by auto-SCT for positive interim [18F] FDG-PET diffuse large B-cell lymphoma patients.
Bone marrow transplantation 2011;46(3):393-9.
2011: Marie Robin; Reza Tabrizi; Mohamad Mohty; Sabine Furst; Mauricette Michallet; Jacques-Olivier Bay; Jean-Yves Cahn; Eric De Coninck; Nathalie Dhedin; Marc Bernard; Bernard Rio; Agnès Buzyn; Anne Huynh; Karin Bilger; Pierre Bordigoni; Nathalie Contentin; Raphaël Porcher; Gérard Socié; Noel Milpied
Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
British journal of haematology 2011;152(3):331-9.
2011: Marie Robin; G F Sanz; Irina Ionescu; Bernard Rio; A Sirvent; M Renaud; Enric Carreras; Noël Milpied; Mohamad Mohty; Y Beguin; Pierre Bordigoni; Theo de Witte; A Picardi; D Purtill; Eliane Gluckman; N Kroger; Vanderson Rocha
Unrelated cord blood transplantation in adults with myelodysplasia or secondary acute myeloblastic leukemia: a survey on behalf of Eurocord and CLWP of EBMT.
Leukemia 2011;25(1):75-81.
2011: Daniel Wolff; Michael Schleuning; Stephanie von Harsdorf; Ulrike Bacher; Armin Gerbitz; Michael Stadler; Francis Ayuk; Alexander Kiani; Rainer Schwerdtfeger; Georgia B Vogelsang; Guido Kobbe; Martin Gramatzki; Anita Lawitschka; Mohamad Mohty; Steven Z Pavletic; Hildegard Greinix; Ernst Holler
Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(1):1-17.
2010: Didier Blaise; Laure Farnault; Catherine Faucher; Nicholas Marchetti; Sabine Fürst; Jean El-Cheikh; Patrick Ladaique; Norbert Vey; Reda Bouabdallah; Anne-Marie Stoppa; Claude Lemarie; Boris Calmels; Thomas Prebet; Luca Castagna; Christian Chabannon; Mohamad Mohty; Benjamin Esterni
Reduced-intensity conditioning with Fludarabin, oral Busulfan, and thymoglobulin allows long-term disease control and low transplant-related mortality in patients with hematological malignancies.
Experimental hematology 2010;38(12):1241-50.
2010: Mohamad Mohty; Myriam Labopin; Liisa Volin; Alois Gratwohl; Gérard Socié; Jordi Esteve; Reza Tabrizi; Arnon Nagler; Vanderson Rocha
Reduced-intensity versus conventional myeloablative conditioning allogeneic stem cell transplantation for patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation.
Blood 2010;116(22):4439-43.
2010: Tobias Feuchtinger; Kathrin Opherk; Wolfgang A Bethge; Max S Topp; Friedhelm R Schuster; Eva M Weissinger; Mohamad Mohty; Reuven Or; Michael Maschan; Michael Schumm; Klaus Hamprecht; Rupert Handgretinger; Peter Lang; Hermann Einsele
Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation.
Blood 2010;116(20):4360-7.
2010: Mohamad Mohty; M Labopin; M L Balère; G Socié; Noël Milpied; R Tabrizi; N Ifrah; Y Hicheri; N Dhedin; M Michallet; A Buzyn; J-Y Cahn; J-H Bourhis; D Blaise; Colette Raffoux; H Espérou; I Yakoub-Agha
Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Sociéte Française de Greffe de Moelle et de Thérapie Cellulaire.
Leukemia 2010;24(11):1867-74.
2010: Jean-Luc Harousseau; Michel Attal; Hervé Avet-Loiseau; Gerald Marit; Denis Caillot; Mohamad Mohty; Pascal Lenain; Cyrille Hulin; Thierry Facon; Philippe Casassus; Mauricette Michallet; Hervé Maisonneuve; Lotfi Benboubker; Frédéric Maloisel; Marie-Odile Petillon; Iain Webb; Claire Mathiot; Philippe Moreau
Bortezomib plus dexamethasone is superior to vincristine plus doxorubicin plus dexamethasone as induction treatment prior to autologous stem-cell transplantation in newly diagnosed multiple myeloma: results of the IFM 2005-01 phase III trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(30):4621-9.
2010: Jean El-Cheikh; Luca Castagna; Ling Wang; Benjamin Esterni; Catherine Faucher; Sabine Fürst; Berger Pierre; Mohamad Mohty; Didier Blaise
Impact of prior invasive aspergillosis on outcome in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplant.
Leukemia & lymphoma 2010;51(9):1705-10.
2010: Aline Clavert; Steven Le Gouill; Eolia Brissot; Viviane Dubruille; Beatrice Mahe; Thomas Gastinne; Nicolas Blin; Patrice Chevallier; Thierry Guillaume; Jacques Delaunay; Sameh Ayari; Beatrice Saulquin; Anne Moreau; Philippe Moreau; Jean-Luc Harousseau; Noël Milpied; Mohamad Mohty
Reduced-intensity conditioning allogeneic stem cell transplant for relapsed or transformed aggressive B-cell non-Hodgkin lymphoma.
Leukemia & lymphoma 2010;51(8):1502-8.
2010: Marion Strullu; Nadège Corradini; Marie Audrain; Jean-Luc Orsonneau; Daniel Bouige; Patrick Thomare; Claudine Vermot-Desroches; Adeline Mansuy; Arnaud Legrand; jean-christophe Rozé; Mohamad Mohty; Françoise Méchinaud
Silent hypersensitivity to Escherichia coli asparaginase in children with acute lymphoblastic leukemia.
Leukemia & lymphoma 2010;51(8):1464-72.
2010: Caroline Bodet-Milin; Cyrille Touzeau; Christophe Leux; Mehmet Sahin; Anne Moreau; Hervé Maisonneuve; Nadine Morineau; Henri Jardel; Philippe Moreau; Céline Gallazini-Crépin; Pascal Gries; Rémy Gressin; Jean-Luc Harousseau; Mohamad Mohty; Philippe Moreau; Françoise Kraeber-Bodere; Steven Le Gouill
Prognostic impact of 18F-fluoro-deoxyglucose positron emission tomography in untreated mantle cell lymphoma: a retrospective study from the GOELAMS group.
European journal of nuclear medicine and molecular imaging 2010;37(9):1633-42.
2010: Steven Z Pavletic; Shaji Kumar; Mohamad Mohty; Marcos de Lima; James M Foran; Marcelo Pasquini; Mei-Jie Zhang; Sergio Giralt; Michael Bishop; Daniel Weisdorf
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(7):871-90.
2010: Mohamad Mohty; Beatrice Gaugler
Advances in umbilical cord transplantation: the role of thymoglobulin/ATG in cord blood transplantation.
Best practice & research. Clinical haematology 2010;23(2):275-82.
2010: A Osama Gaber; Anthony P Monaco; James A Russell; Yvon Lebranchu; Mohamad Mohty
Rabbit antithymocyte globulin (thymoglobulin): 25 years and new frontiers in solid organ transplantation and haematology.
Drugs 2010;70(6):691-732.
2010: E Brissot; Patrice Chevallier; T Guillaume; J Delaunay; S Ayari; V Dubruille; Steven Le Gouill; B Mahe; Thomas Gastinne; N Blin; B Saulquin; Philippe Moreau; Jean-Luc Harousseau; Mohamad Mohty
Prophylaxis with mycophenolate mofetil and CsA can decrease the incidence of severe acute GVHD after antithymocyte globulin-based reduced-intensity preparative regimen and allo-SCT from HLA-matched unrelated donors.
Bone marrow transplantation 2010;45(4):786-8.
2010: Bilal Mohty; Jean El-Cheikh; Ibrahim Yakoub-Agha; Philippe Moreau; Jean-Luc Harousseau; Mohamad Mohty
Peripheral neuropathy and new treatments for multiple myeloma: background and practical recommendations.
Haematologica 2010;95(2):311-9.
2010: Xiao Ma; Depei Wu; Aining Sun; Huiying Qiu; Zhenzhen Fu; Xiaojin Wu; Suning Chen; Mohamad Mohty
The value of monitoring minimal residual disease in the patients with donor lymphocyte infusion as intervention of relapsed/refractory acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation.
American journal of hematology 2010;85(2):141-2.
2010: Mohamad Mohty; Jane F Apperley
Long-term physiological side effects after allogeneic bone marrow transplantation.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2010;2010():229-36.
2010: Jean El-Cheikh; Luca Castagna; Ling Wang; Benjamin Esterni; Catherine Faucher; Sabine Furst; Segolene Duran; Pierre Berger; Stéphane Ranque; Mohamad Mohty; Didier Blaise
Once-weekly liposomal amphotericin B for prophylaxis of invasive fungal infection after graft-versus-host disease in allogeneic hematopoietic stem cell transplantation: a comparative retrospective single-center study.
Hematology/oncology and stem cell therapy 2010;3(4):167-73.
2010: Florent Malard; Richard M Szydlo; Eolia Brissot; Patrice Chevallier; Thierry Guillaume; Jacques Delaunay; Sameh Ayari; Viviane Dubruille; Steven Le Gouill; Beatrice Mahe; Thomas Gastinne; Nicolas Blin; Beatrice Saulquin; Jean-Luc Harousseau; Philippe Moreau; Mohamad Mohty
Impact of cyclosporine-A concentration on the incidence of severe acute graft-versus-host disease after allogeneic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(1):28-34.
2010: Thomas Prébet; Patrick Ladaique; Martin Ferrando; Christian Chabannon; Catherine Faucher; Hugues de Lavallade; Jean El-Cheikh; Sabine Furst; Norbert Vey; Anne-Marie Stoppa; Patrice Viens; Didier Blaise; Mohamad Mohty
Platelet recovery and transfusion needs after reduced intensity conditioning allogeneic peripheral blood stem cell transplantation.
Experimental hematology 2010;38(1):55-60.
2010: Anne Sirvent; Nathalie Dhedin; Mauricette Michallet; Nicolas Mounier; Catherine Faucher; Ibrahim Yakoub-Agha; Mohamad Mohty; Marie Robin; Reza Tabrizi; Laurence Clement; Karin Bilger; Fabrice Larosa; Nathalie Contentin; Anne Huyn; Sylvie François; Claude-Eric Bulabois; Patrice Ceballos; Jean-Henri Bourrhis; Agnès Buzyn; Jérôme Cornillon; Gaelle Guillerm; Thierry de Revel; Jacques-Olivier Bay; François Guilhot; Noël Milpied
Low nonrelapse mortality and prolonged long-term survival after reduced-intensity allogeneic stem cell transplantation for relapsed or refractory diffuse large B cell lymphoma: report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(1):78-85.
2010: Patrice Chevallier; T Prebet; P Turlure; Mathilde Hunault; Stéphane Vigouroux; Jean-Luc Harousseau; Didier Blaise; Norbert Ifrah; Noël Milpied; Mohamad Mohty
Prior treatment with gemtuzumab ozogamicin and the risk of veno-occlusive disease after allogeneic haematopoietic stem cell transplantation.
Bone marrow transplantation 2010;45(1):165-70.
2010: Anne-Marie Mohty; Jean-Jacques Grob; Mohamad Mohty; Marie-Aleth Richard; Daniel Olive; Béatrice Gaugler
Induction of IP-10/CXCL10 secretion as an immunomodulatory effect of low-dose adjuvant interferon-alpha during treatment of melanoma.
Immunobiology 2010;215(2):113-23.
2009: Xavier Cahu; Fanny Rialland; Cyrille Touzeau; Patrice Chevallier; Thierry Guillaume; Jacques Delaunay; Sameh Ayari; Viviane Dubruille; Steven Le Gouill; Beatrice Mahe; Thomas Gastinne; Nicolas Blin; Beatrice Saulquin; Jean-Luc Harousseau; Philippe Moreau; Mohamad Mohty
Infectious complications after unrelated umbilical cord blood transplantation in adult patients with hematologic malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(12):1531-7.
2009: E Brissot; P Chevallier; T Guillaume; J Delaunay; S Ayari; V Dubruille; Steven Le Gouill; B Mahe; Thomas Gastinne; N Blin; B Saulquin; G Flandrois; A Devys; V Stocco; A Cesbron; F Dehaut; Philippe Moreau; Jean-Luc Harousseau; Mohamad Mohty
Factors predicting allogeneic PBSCs yield after G-CSF treatment in healthy donors.
Bone marrow transplantation 2009;44(9):613-5.
2009: Olle Ringdén; Myriam Labopin; Gerhard Ehninger; Dietger Niederwieser; Richard Olsson; Nadezda Basara; Juergen Finke; Rainer Schwerdtfeger; Matthias Eder; Donald Bunjes; Norbert-Claude Gorin; Mohamad Mohty; Vanderson Rocha
Reduced intensity conditioning compared with myeloablative conditioning using unrelated donor transplants in patients with acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(27):4570-7.
2009: Mohamed A Kharfan-Dabaja; Asmita R Mhaskar; Benjamin Djulbegovic; Corey Cutler; Mohamad Mohty; Ambuj Kumar
Efficacy of rituximab in the setting of steroid-refractory chronic graft-versus-host disease: a systematic review and meta-analysis.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(9):1005-13.
2009: Leonardo Magro; Mohamad Mohty; Benoit Catteau; Valérie Coiteux; Patrice Chevallier; Louis Terriou; Jean-Pierre Jouet; Ibrahim Yakoub-Agha
Imatinib mesylate as salvage therapy for refractory sclerotic chronic graft-versus-host disease.
Blood 2009;114(3):719-22.
2009: Vanderson Rocha; Mohamad Mohty; Eliane Gluckman; Bernard Rio
Reduced-intensity conditioning regimens before unrelated cord blood transplantation in adults with acute leukaemia and other haematological malignancies.
Current opinion in oncology 2009;21 Suppl 1():S31-4.
2009: Mohamad Mohty; Vanderson Rocha; Patrice Chevallier; Jean-Luc Harousseau; Arnon Nagler
Reduced-intensity conditioning for allogeneic stem cell transplantation: 10 years later.
Current opinion in oncology 2009;21 Suppl 1():S1.
2009: R Willemze; Celso Rodrigues; Myriam Labopin; G Sanz; Gérard Michel; Gérard Socié; Bernard Rio; A Sirvent; M Renaud; L Madero; Mohamad Mohty; C Ferra; Federico Garnier; Pascale Loiseau; J Garcia; L Lecchi; G Kögler; Y Beguin; C Navarrete; T Devos; Irina Ionescu; K Boudjedir; A-L Herr; Eliane Gluckman; Vanderson Rocha
KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia.
Leukemia 2009;23(3):492-500.
2009: Celso Rodrigues; Guillermo Sanz; Claudio G Brunstein; Jaime Sanz; John E Wagner; Marc Renaud; Marcos de Lima; Mitchell S Cairo; Sabine Fürst; Bernard Rio; Christopher Dalley; Enric Carreras; Jean-Luc Harousseau; Mohamad Mohty; Denis Taveira; Peter Dreger; Anna Sureda; Eliane Gluckman; Vanderson Rocha
Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(2):256-63.
2008: Mohamad Mohty
[Allogeneic hematopoietic stem cell transplantation].
La Revue du praticien 2008;58(19):2111-22.
2008: Patrice Chevallier; Nelly Robillard; Sameh Ayari; Thierry Guillaume; Jacques Delaunay; Francoise Mechinaud; Herve Avet-Loiseau; Mohamad Mohty; Jean-Luc Harousseau; Richard Garand
Persistence of CD33 expression at relapse in CD33(+) acute myeloid leukaemia patients after receiving Gemtuzumab in the course of the disease.
British journal of haematology 2008;143(5):744-6.
2008: Patrice Chevallier; Jacques Delaunay; Pascal Turlure; Arnaud Pigneux; Mathilde Hunault; Richard Garand; Thierry Guillaume; Hervé Avet-Loiseau; Nathalia Dmytruk; Stephane Girault; Noël Milpied; Norbert Ifrah; Mohamad Mohty; Jean-Luc Harousseau
Long-term disease-free survival after gemtuzumab, intermediate-dose cytarabine, and mitoxantrone in patients with CD33(+) primary resistant or relapsed acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(32):5192-7.
2008: Philippe Moreau; Frédéric Garban; Michel Attal; Mauricette Michallet; Gérald Marit; Cyrille Hulin; Lotfi Benboubker; Chantal Doyen; Mohamad Mohty; Ibrahim Yakoub-Agha; Serge Leyvraz; Philippe Casassus; Hervé Avet-Loiseau; Laurent Garderet; Claire Mathiot; Jean-Luc Harousseau
Long-term follow-up results of IFM99-03 and IFM99-04 trials comparing nonmyeloablative allotransplantation with autologous transplantation in high-risk de novo multiple myeloma.
Blood 2008;112(9):3914-5.
2008: Patrice Chevallier; Mohamad Mohty; Bruno Lioure; Gerard Michel; Nathalie Contentin; Eric DECONINCK; Pierre Bordigoni; Jean-Paul Vernant; Mathilde Hunault; Stéphane Vigouroux; Didier Blaise; Reza Tabrizi; Agnes Buzyn; Gerard Socie; Mauricette Michallet; Christelle Volteau; Jean-Luc Harousseau
Allogeneic hematopoietic stem-cell transplantation for myeloid sarcoma: a retrospective study from the SFGM-TC.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(30):4940-3.
2008: Régis Peffault de Latour; Jean-Yves Mary; Célia Salanoubat; Louis Terriou; Gabriel Etienne; Mohamad Mohty; Sophie Roth; SOPHIE DE GUIBERT; Sebastien Maury; Jean Yves Cahn; Gérard Socié
Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories.
Blood 2008;112(8):3099-106.
2008: Mohamad Mohty; Beatrice Gaugler
Mechanisms of action of antithymocyte globulin: old dogs with new tricks!
Leukemia & lymphoma 2008;49(9):1664-7.
2008: Hugues de Lavallade; Philippe A Cassier; Reda Bouabdallah; Jean El-Cheikh; Catherine Faucher; Sabine Fürst; Diane Coso; Danielle Sainty; Christine Arnoulet; Jean-Albert Gastaut; Bruno Chetaille; Luc Xerri; Didier Blaise; Mohamad Mohty
Sustained response after reduced-intensity conditioning allogeneic stem cell transplantation for patients with relapsed peripheral T-cell non-Hodgkin lymphoma.
British journal of haematology 2008;142(5):848-50.
2008: Mohamad Mohty; Richard Szydlo; Agnes S M Yong; Jane F Apperley; John M Goldman; Junia V Melo
Association between BMI-1 expression, acute graft-versus-host disease, and outcome following allogeneic stem cell transplantation from HLA-identical siblings in chronic myeloid leukemia.
Blood 2008;112(5):2163-6.
2008: Jean El-Cheikh; Anne-Marie Stoppa; Reda Bouabdallah; Hugues de Lavallade; Diane Coso; Jean-Marc Schiano de Collela; Thérèse Auran-Schleinitz; Jean-Albert Gastaut; Didier Blaise; Mohamad Mohty
Features and risk factors of peripheral neuropathy during treatment with bortezomib for advanced multiple myeloma.
Clinical lymphoma & myeloma 2008;8(3):146-52.
2008: Mohamad Mohty
Systemic lupus erythematosus.
The New England journal of medicine 2008;358(22):2412-3; author reply 2413.
2008: Steven Le Gouill; Noël Milpied; Agnès Buzyn; Régis Peffault de Latour; Jean-Paul Vernant; Mohamad Mohty; Marie-Pierre Moles; Krimo Bouabdallah; Claude-Eric Bulabois; Jehan Dupuis; Bernard Rio; Nicole Gratecos; Ibrahim Yakoub-Agha; Michel Attal; Olivier Tournilhac; Didier Decaudin; Jean-Henry Bourhis; Didier Blaise; Christelle Volteau; Mauricette Michallet
Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: a study by the Société Francaise de Greffe de Moëlle et de Thérapie Cellulaire.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(14):2264-71.
2008: Mauricette Michallet; Quoc-Hung Le; Mohamad Mohty; Thomas Prébet; Franck E Nicolini; Jean-Michel Boiron; Hélène Esperou; Michel Attal; Noël Milpied; Bruno Lioure; Pierre Bordigoni; Ibrahim Yakoub-Agha; Jean-Henri Bourhis; Bernard Rio; Eric DECONINCK; Marc Renaud; Zina Chir; Didier Blaise
Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
Experimental hematology 2008;36(5):535-44.
2008: Mohamad Mohty; N Marchetti; J El-Cheikh; Catherine Faucher; S Fürst; Didier Blaise
Rituximab as salvage therapy for refractory chronic GVHD.
Bone marrow transplantation 2008;41(10):909-11.
2008: Jean El-Cheikh; Mauricette Michallet; Arnon Nagler; Hugues de Lavallade; Franck E Nicolini; Avichai Shimoni; Catherine Faucher; Mohamad Sobh; Daniela Revesz; Izhar Hardan; Sabine Fürst; Didier Blaise; Mohamad Mohty
High response rate and improved graft-versus-host disease following bortezomib as salvage therapy after reduced intensity conditioning allogeneic stem cell transplantation for multiple myeloma.
Haematologica 2008;93(3):455-8.
2008: Mohamad Mohty; Myriam Labopin; Reza Tabrizzi; Niklas Theorin; Axel A Fauser; Alessandro Rambaldi; Johan Maertens; Shimon Slavin; Ignazio Majolino; Arnon Nagler; Didier Blaise; Vanderson Rocha
Reduced intensity conditioning allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation.
Haematologica 2008;93(2):303-6.
2008: Catherine Cordonnier; Mohamad Mohty; Catherine Faucher; Cécile Pautas; Marie Robin; Norbert Vey; Françoise Monchecourt; Lamine Mahi; Patricia Ribaud
Safety of a weekly high dose of liposomal amphotericin B for prophylaxis of invasive fungal infection in immunocompromised patients: PROPHYSOME Study.
International journal of antimicrobial agents 2008;31(2):135-41.
2008: Mohamad Mohty; Béatrice Gaugler
Inflammatory cytokines and dendritic cells in acute graft-versus-host disease after allogeneic stem cell transplantation.
Cytokine & growth factor reviews 2008;19(1):53-63.
2008: Naira Ben Mami; Mohamad Mohty; T Aurran-Schleinitz; Daniel Olive; Béatrice Gaugler
Blood dendritic cells in patients with chronic lymphocytic leukaemia.
Immunobiology 2008;213(6):493-8.
2007: Mohamad Mohty
Dendritic cells and acute graft-versus-host disease after allogeneic stem cell transplantation.
Leukemia & lymphoma 2007;48(9):1696-701.
2007: Philippe Moreau; Michel Attal; Frédéric Garban; Cyrille Hulin; Thierry Facon; Gérald Marit; Mauricette Michallet; Chantal Doyen; S Leyvraz; Mohamad Mohty; Marc Wetterwald; Claire Mathiot; Denis Caillot; Christian Berthou; Lotfi Benboubker; Laurent Garderet; Carine Chaleteix; Catherine Traullé; Jean-Gabriel Fuzibet; Jérôme Jaubert; Thierry Lamy; Philippe Casassus; M Dib; B Kolb; Véronique Dorvaux; Bernard Grosbois; Ibrahim Yakoub-Agha; Jean-Luc Harousseau; Hervé Avet-Loiseau
Heterogeneity of t(4;14) in multiple myeloma. Long-term follow-up of 100 cases treated with tandem transplantation in IFM99 trials.
Leukemia 2007;21(9):2020-4.
2007: Mohamad Mohty; Odile Avinens; Catherine Faucher; Patrice Viens; Didier Blaise; Jean-François Eliaou
Predictive factors and impact of full donor T-cell chimerism after reduced intensity conditioning allogeneic stem cell transplantation.
Haematologica 2007;92(7):1004-6.
2007: J-C Meniane; Jean El-Cheikh; Catherine Faucher; Sabine Fürst; Reda Bouabdallah; Didier Blaise; Mohamad Mohty
Long-term graft-versus-Waldenström macroglobulinemia effect following reduced intensity conditioning allogeneic stem cell transplantation.
Bone marrow transplantation 2007;40(2):175-7.
2007: Mohamad Mohty
Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond.
Leukemia 2007;21(7):1387-94.
2007: Mohamad Mohty; Agnes S M Yong; Richard Szydlo; Jane F Apperley; Junia V Melo
The polycomb group BMI1 gene is a molecular marker for predicting prognosis of chronic myeloid leukemia.
Blood 2007;110(1):380-3.
2007: Didier Blaise; Norbert Vey; Catherine Faucher; Mohamad Mohty
Current status of reduced-intensity-conditioning allogeneic stem cell transplantation for acute myeloid leukemia.
Haematologica 2007;92(4):533-41.
2007: Jean El-Cheikh; Catherine Faucher; Sabine Fürst; S Duran; P Berger; Norbert Vey; Anne-Marie Stoppa; Reda Bouabdallah; Jean-Albert Gastaut; Patrice Viens; Didier Blaise; Mohamad Mohty
High-dose weekly liposomal amphotericin B antifungal prophylaxis following reduced-intensity conditioning allogeneic stem cell transplantation.
Bone marrow transplantation 2007;39(5):301-6.
2006: Hugues de Lavallade; Mohamad Mohty; Jean El-Cheikh; Philippe A Cassier; Catherine Faucher; Sabine Fürst; Norbert Vey; Anne-Marie Stoppa; Danielle Sainty; Christine Arnoulet; Luc Xerri; Jean-Albert Gastaut; Didier Blaise; Reda Bouabdallah
Reduced-intensity conditioning allogeneic stem cell transplantation for patients with chemoresistant or relapsed follicular lymphoma.
British journal of haematology 2006;135(3):408-10.
2006: Hugues de Lavallade; Mohamad Mohty; Catherine Faucher; Sabine Fürst; Jean El-Cheikh; Didier Blaise
Low-dose methotrexate as salvage therapy for refractory graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation.
Haematologica 2006;91(10):1438-40.
2006: Hugues de Lavallade; Catherine Faucher; Sabine Fürst; Jean El-Cheikh; Norbert Vey; Diane Coso; Reda Bouabdallah; Anne-Marie Stoppa; Jean-Albert Gastaut; Didier Blaise; Mohamad Mohty
Allogeneic stem cell transplantation after reduced-intensity conditioning in a patient with T-cell prolymphocytic leukemia: graft-versus-tumor effect and long-term remission.
Bone marrow transplantation 2006;37(7):709-10.
2005: Mohamad Mohty; Didier Blaise; Catherine Faucher; Norbert Vey; Reda Bouabdallah; Anne-Marie Stoppa; Frédéric Viret; Gwenaelle Gravis; Daniel Olive; Béatrice Gaugler
Inflammatory cytokines and acute graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation.
Blood 2005;106(13):4407-11.
2005: Didier Blaise; Jean Michel Boiron; Catherine Faucher; Mohamad Mohty; Jacques-Olivier Bay; Valerie-Jeanne Bardoux; Virginie Perreau; Diane Coso; Arnaud Pigneux; Norbert Vey
Reduced intensity conditioning prior to allogeneic stem cell transplantation for patients with acute myeloblastic leukemia as a first-line treatment.
Cancer 2005;104(9):1931-8.
2005: V Ivanov; Catherine Faucher; Mohamad Mohty; Karin Bilger; Patrick Ladaique; Danielle Sainty; Christine Arnoulet; Christian Chabannon; Norbert Vey; Jacques Camerlo; Reda Bouabdallah; Patrice Viens; Dominique Maraninchi; Valérie-Jeanne Bardou; Benjamin Esterni; Didier Blaise
Early administration of recombinant erythropoietin improves hemoglobin recovery after reduced intensity conditioned allogeneic stem cell transplantation.
Bone marrow transplantation 2005;36(10):901-6.
2005: Mohamad Mohty
CD25 expression on donor CD8+ T cells and graft-versus-host disease.
Haematologica 2005;90(10):1302A.
2005: Mohamad Mohty; Didier Blaise; Daniel Olive; Béatrice Gaugler
Imatinib: the narrow line between immune tolerance and activation.
Trends in molecular medicine 2005;11(9):397-402.
2005: Mohamad Mohty; Hugues de Lavallade; Patrick Ladaique; Catherine Faucher; Norbert Vey; Diane Coso; Anne-Marie Stoppa; Jean-Albert Gastaut; Didier Blaise
The role of reduced intensity conditioning allogeneic stem cell transplantation in patients with acute myeloid leukemia: a donor vs no donor comparison.
Leukemia 2005;19(6):916-20.
2005: Mohamad Mohty; Catherine Faucher; Didier Blaise
Graft-versus-host-disease and granulocyte colony-stimulating factor administration after allogeneic stem cell transplantation.
Leukemia 2005;19(4):500-3.
2005: Gandhi Damaj; Reda Bouabdallah; Norbert Vey; Karin Bilger; Mohamad Mohty; Jean-Albert Gastaut
Single-agent thalidomide induces response in T-cell lymphoma.
European journal of haematology 2005;74(2):169-71.
2005: Didier Blaise; Mohamad Mohty; Catherine Faucher; Daniel Olive; Christian Chabannon
Current update on reduced intensity regimens for allogeneic stem cell transplantation.
Hematology (Amsterdam, Netherlands) 2005;10 Suppl 1():64-5.
2005: Mohamad Mohty; Michel Attal; Gérald Marit; Claude-Eric Bulabois; Frédéric Garban; Nicole Gratecos; Bernard Rio; Jean-Paul Vernant; Jean-Jacques Sotto; Jean-Yves Cahn; Didier Blaise; Jean-Pierre Jouet; Thierry Facon; Ibrahim Yakoub-Agha
Thalidomide salvage therapy following allogeneic stem cell transplantation for multiple myeloma: a retrospective study from the Intergroupe Francophone du Myélome (IFM) and the Société Française de Greffe de Moelle et Thérapie Cellulaire (SFGM-TC).
Bone marrow transplantation 2005;35(2):165-9.
2005: Mohamad Mohty; Didier Blaise; Catherine Faucher; Valérie-Jeanne Bardou; Jean-Albert Gastaut; Patrice Viens; Daniel Olive; Béatrice Gaugler
Impact of plasmacytoid dendritic cells on outcome after reduced-intensity conditioning allogeneic stem cell transplantation.
Leukemia 2005;19(1):1-6.
2004: Gandhi Damaj; Mohamad Mohty; Norbert Vey; E Dincan; Reda Bouabdallah; Catherine Faucher; Anne-Marie Stoppa; Jean-Albert Gastaut
Features of extramedullary and extraosseous multiple myeloma: a report of 19 patients from a single center.
European journal of haematology 2004;73(6):402-6.
2004: Mohamad Mohty; Sophie Bagattini; Christian Chabannon; Catherine Faucher; Valérie-Jeanne Bardou; Karin Bilger; Norbert Vey; Béatrice Gaugler; Anne-Marie Stoppa; Diane Coso; Patrick Ladaique; Daniel Olive; Patrice Viens; Didier Blaise
CD8+ T cell dose affects development of acute graft-vs-host disease following reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation.
Experimental hematology 2004;32(11):1097-102.
2004: Mohamad Mohty; Hugues de Lavallade; Catherine Faucher; Karin Bilger; Norbert Vey; Anne-Marie Stoppa; Gwenaelle Gravis; Diane Coso; Patrice Viens; Jean-Albert Gastaut; Didier Blaise
Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantation.
Bone marrow transplantation 2004;34(6):527-30.
2004: Mohamad Mohty; Daniel Olive; Béatrice Gaugler
Plasmacytoid DCs and cancer: a new role for an enigmatic cell.
Trends in immunology 2004;25(8):397-8; author reply 398-9.
2004: Naira Ben Mami; Mohamad Mohty; Hervé Chambost; Béatrice Gaugler; Daniel Olive
Blood dendritic cells in patients with acute lymphoblastic leukaemia.
British journal of haematology 2004;126(1):77-80.
2004: Mohamad Mohty; Jean-Michel Boiron; Gandhi Damaj; Anne-Sophie Michallet; Jacques-Olivier Bay; Catherine Faucher; Virginie Perreau; Karin Bilger; Diane Coso; Anne-Marie Stoppa; Reza Tabrizi; Jean-Albert Gastaut; Mauricette Michallet; Dominique Maraninchi; Didier Blaise
Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantation.
Bone marrow transplantation 2004;34(1):77-84.
2004: Mohamad Mohty; Eric Jourdan; Naira Ben Mami; Norbert Vey; Gandhi Damaj; Didier Blaise; Daniel Isnardon; Daniel Olive; Béatrice Gaugler
Imatinib and plasmacytoid dendritic cell function in patients with chronic myeloid leukemia.
Blood 2004;103(12):4666-8.
2004: V Ivanov; Catherine Faucher; Mohamad Mohty; Karin Bilger; Patrick Ladaique; Danielle Sainty; Christine Arnoulet; Christian Chabannon; Norbert Vey; Jacques Camerlo; Reda Bouabdallah; Dominique Maraninchi; Valérie-Jeanne Bardou; Didier Blaise
Decreased RBCTs after reduced intensity conditioning allogeneic stem cell transplantation: predictive value of prior Hb level.
Transfusion 2004;44(4):501-8.
2004: Mohamad Mohty; A M Mohty; Didier Blaise; Catherine Faucher; Karin Bilger; Daniel Isnardon; Danielle Sainty; Jean-Albert Gastaut; Patrice Viens; Daniel Olive; Béatrice Gaugler
Cytomegalovirus-specific immune recovery following allogeneic HLA-identical sibling transplantation with reduced-intensity preparative regimen.
Bone marrow transplantation 2004;33(8):839-46.
2004: Alexandra Vialle-Castellano; Béatrice Gaugler; Mohamad Mohty; Daniel Isnardon; Nicolas van Baren; Daniel Olive
Abundant expression of fibronectin is a major feature of leukemic dendritic cells differentiated from patients with acute myeloid leukemia.
Leukemia 2004;18(3):426-33.
2004: Didier Blaise; Jacques-Olivier Bay; Catherine Faucher; Mauricette Michallet; Jean-Michel Boiron; Bachra Choufi; Jean-Yves Cahn; Nicole Gratecos; Jean-Jacques Sotto; Sylvie François; Joel Fleury; Mohamad Mohty; Christian Chabannon; Karin Bilger; Gwenaelle Gravis; Frédéric Viret; Anne-Chantal Braud; Valérie-Jeanne Bardou; Dominique Maraninchi; Patrice Viens
Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors.
Blood 2004;103(2):435-41.
2004: Julie Véran; Mohamad Mohty; Béatrice Gaugler; Carlo Chiavaroli; Daniel Olive
OM-197-MP-AC adjuvant properties: the in vitro maturation of normal and leukemic dendritic cells in a serum-free culture model.
Immunobiology 2004;209(1-2):67-77.
2003: V Ivanov; Catherine Faucher; Karin Bilger; Norbert Vey; Danielle Sainty; Boris Calmels; Christian Chabannon; Marina Lafage-Pochitaloff; Marie-Joëlle Mozziconacci; Mohamad Mohty; M A Chrestian; Didier Blaise
Massive ascites of donor T-cell origin in a patient with acute GVHD after a reduced-intensity allograft for CLL.
Bone marrow transplantation 2003;32(9):961-3.
2003: Mohamad Mohty; W Jacot; Catherine Faucher; Jacques-Olivier Bay; Christine Zandotti; L Collet; Bachra Choufi; Karin Bilger; Olivier Tournilhac; Norbert Vey; Anne-Marie Stoppa; Diane Coso; Jean-Albert Gastaut; Patrice Viens; Dominique Maraninchi; Daniel Olive; Didier Blaise
Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen.
Leukemia 2003;17(11):2168-77.
2003: Catherine Faucher; Mohamad Mohty; Norbert Vey; Béatrice Gaugler; Karin Bilger; Marie-Joelle Moziconnacci; Anne-Marie Stoppa; Diane Coso; Patrick Ladaique; Christian Chabannon; Denis Reviron; Dominique Maraninchi; Jean-Albert Gastaut; Daniel Olive; Didier Blaise
Bone marrow as stem cell source for allogeneic HLA-identical sibling transplantation following reduced-intensity preparative regimen.
Experimental hematology 2003;31(10):873-80.
2003: Mohamad Mohty; Alexandra Vialle-Castellano; Jacques Nunès; Daniel Isnardon; Daniel Olive; Béatrice Gaugler
IFN-alpha skews monocyte differentiation into Toll-like receptor 7-expressing dendritic cells with potent functional activities.
Journal of immunology (Baltimore, Md. : 1950) 2003;171(7):3385-93.
2003: Mohamad Mohty; Béatrice Gaugler
Dendritic cells: interfaces with immunobiology and medicine. A report from the Keystone Symposia Meeting held in Keystone, 3-8 March 2003.
Leukemia 2003;17(9):1753-8.
2003: Mohamad Mohty; Silvia Morbelli; Daniel Isnardon; Danielle Sainty; Christine Arnoulet; Béatrice Gaugler; Daniel Olive
All-trans retinoic acid skews monocyte differentiation into interleukin-12-secreting dendritic-like cells.
British journal of haematology 2003;122(5):829-36.
2003: Mohamad Mohty; Béatrice Gaugler; Boris Calmels; Didier Blaise; Norbert Vey; Christian Chabannon; Daniel Olive
[Immunotherapy of acute myeloid leukemias: development of vaccines and cell therapy approaches].
Bulletin du cancer 2003;90(8-9):751-7.
2003: Mohamad Mohty; Jacques-Olivier Bay; Catherine Faucher; Bachra Choufi; Karin Bilger; Olivier Tournilhac; Norbert Vey; Anne-Marie Stoppa; Diane Coso; Christian Chabannon; Patrice Viens; Dominique Maraninchi; Didier Blaise
Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin-based reduced-intensity preparative regimen.
Blood 2003;102(2):470-6.
2003: Mohamad Mohty; Daniel Olive
[Can one separate GVH and GVT after allogenic hematopoietic stem cell transplantation?].
Médecine sciences : M/S 2003;19(5):540-1.
2003: Mohamad Mohty; Karin Bilger; Eric Jourdan; Mathieu Kuentz; Mauricette Michallet; Jean-Henri Bourhis; Noël Milpied; L Sutton; Jean-Pierre Jouet; Michel Attal; Pierre Bordigoni; Jean-Yves Cahn; Alain Sadoun; Norbert Ifrah; Denis Guyotat; Catherine Faucher; Nathalie Fegueux; Josy Reiffers; Dominique Maraninchi; Didier Blaise
Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation.
Leukemia 2003;17(5):869-75.
2003: Mohamad Mohty; Béatrice Gaugler; Daniel Olive
Generation of leukemic dendritic cells from patients with acute myeloid leukemia.
Methods in molecular biology (Clifton, N.J.) 2003;215():463-71.
2002: Mohamad Mohty; Anne-Marie Stoppa; Didier Blaise; Daniel Isnardon; Jean-Albert Gastaut; Daniel Olive; Béatrice Gaugler
Differential regulation of dendritic cell function by the immunomodulatory drug thalidomide.
Journal of leukocyte biology 2002;72(5):939-45.
2002: Mohamad Mohty; Daniel Isnardon; Didier Blaise; Marie-Joëlle Mozziconacci; Marina Lafage-Pochitaloff; Francine Brière; Jean-Albert Gastaut; Daniel Olive; Béatrice Gaugler
Identification of precursors of leukemic dendritic cells differentiated from patients with acute myeloid leukemia.
Leukemia 2002;16(11):2267-74.
2002: Mohamad Mohty; Daniel Olive; Béatrice Gaugler
Leukemic dendritic cells: potential for therapy and insights towards immune escape by leukemic blasts.
Leukemia 2002;16(11):2197-204.
2002: Mohamad Mohty; Mathieu Kuentz; Mauricette Michallet; Jean-Henri Bourhis; Noël Milpied; Laurent Sutton; Jean-Pierre Jouet; Michel Attal; Pierre Bordigoni; Jean-Yves Cahn; Jean-Michel Boiron; Didier Blaise
Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study.
Blood 2002;100(9):3128-34.
2002: Mohamad Mohty; Daniel Isnardon; Norbert Vey; Francine Brière; Didier Blaise; Daniel Olive; Béatrice Gaugler
Low blood dendritic cells in chronic myeloid leukaemia patients correlates with loss of CD34+/CD38- primitive haematopoietic progenitors.
British journal of haematology 2002;119(1):115-8.
2002: Mohamad Mohty; Catherine Faucher; Norbert Vey; Christian Chabannon; Danielle Sainty; Christine Arnoulet; Béatrice Gaugler; Jean-Albert Gastaut; Dominique Maraninchi; Daniel Olive; Didier Blaise
Features of large granular lymphocytes (LGL) expansion following allogeneic stem cell transplantation: a long-term analysis.
Leukemia 2002;16(10):2129-33.
2002: Mohamad Mohty; Daniel Isnardon; Aude Charbonnier; Marina Lafage-Pochitaloff; Michele Merlin; Danielle Sainty; Daniel Olive; Béatrice Gaugler
Generation of potent T(h)1 responses from patients with lymphoid malignancies after differentiation of B lymphocytes into dendritic-like cells.
International immunology 2002;14(7):741-50.
2002: Mohamad Mohty; Béatrice Gaugler; Catherine Faucher; Danielle Sainty; Marina Lafage-Pochitaloff; Norbert Vey; Reda Bouabdallah; Christine Arnoulet; Jean-Albert Gastaut; Frédéric Viret; J Wolfers; Dominique Maraninchi; Didier Blaise; D Olive
Recovery of lymphocyte and dendritic cell subsets following reduced intensity allogeneic bone marrow transplantation.
Hematology (Amsterdam, Netherlands) 2002;7(3):157-64.
2001: Mohamad Mohty; D Jarrossay; Marina Lafage-Pochitaloff; Christine Zandotti; Francine Brière; X N de Lamballeri; Daniel Isnardon; Danielle Sainty; Daniel Olive; Béatrice Gaugler
Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment.
Blood 2001;98(13):3750-6.
2001: Mohamad Mohty; Catherine Faucher; Béatrice Gaugler; Norbert Vey; Danielle Sainty; Christine Arnoulet; Marie-Joëlle Mozziconacci; Daniel Isnardon; Jean-Albert Gastaut; Dominique Maraninchi; Daniel Olive; Didier Blaise
Large granular lymphocytes (LGL) following non-myeloablative allogeneic bone marrow transplantation: a case report.
Bone marrow transplantation 2001;28(12):1157-60.
2001: Mohamad Mohty; Nathalie Fegueux; C Exbrayat; Zhao-Yang Lu; Eric Legouffe; Philippe Quittet; E Lopez-Martinez; Pascal Latry; Odile Avinens; C Hertog; Bernard Klein; Jean-François Eliaou; Jean-François Rossi
Reduced intensity conditioning: enhanced graft-versus-tumor effect following dose-reduced conditioning and allogeneic transplantation for refractory lymphoid malignancies after high-dose therapy.
Bone marrow transplantation 2001;28(4):335-9.
2001: Mohamad Mohty; B Albat; Nathalie Fegueux; Jean-François Rossi
Autologous peripheral blood stem cell transplantation following heart transplantation for primary systemic amyloidosis.
Leukemia & lymphoma 2001;41(1-2):221-3.
2000: Mohamad Mohty; Catherine Faucher; Norbert Vey; Anne-Marie Stoppa; Frédéric Viret; I Chabbert; Christian Chabannon; Reda Bouabdallah; Patrick Ladaique; L Collet; Christine Zandotti; Dominique Maraninchi; Didier Blaise
High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation.
Bone marrow transplantation 2000;26(3):251-5.
2000: Mohamad Mohty; Catherine Faucher; Christian Chabannon; Norbert Vey; Anne-Marie Stoppa; Patrick Ladaique; G Novakovitch; S Olivero; Reda Bouabdallah; Jean-Albert Gastaut; Dominique Maraninchi; Didier Blaise
CD34(+) immunoselected cells for poor graft function following allogeneic BMT.
Cytotherapy 2000;2(5):367-70.